J&J teams with Microsoft for biologics

Johnson & Johnson's IT-savvy pharma R&D group turned to Microsoft Research for help in expanding its small-molecule drug-development platform into biologics development. The attraction: the open-source library of bioinformatics functions within the Microsoft Biology Foundation, part of the Microsoft Biology Initiative.

Like other free, open-source software offerings, MBF provides programmers some prewritten functionality on which they can build, says R&D magazine. That translates into a big head start over an in-house platform development effort; programmers jumped right into developing a greater level of functionality for drug developers.

The J&J group also has distinguished itself as an early adopter of cloud computing.

- here's the story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.